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Abstract 
Background: Arthritis is one of the most common inflammatory diseases worldwide. It is 
characterized by symptoms such as systemic inflammation and autoantibody production. The 
molecular mechanisms in pathogenesis of arthritis are not fully understood. Studies show that 
many microorganisms, including Mycoplasmas, play a role in arthritis. The PCR method is a 
fast and accurate molecular method for the detection of Mycoplasma genus. The main 
objective of this study is the detection of Mycoplasma spp arthritis by PCR method. 
Methods: In this study, 70 samples of synovial fluid collected from Shariati hospital. DNA 
samples were extracted by phenol-chloroform standard method. Using several Mycoplasma 
standard strains and 16S rRNA gene target optimized PCR test of Mycoplasma spp. 
Sensitivity and specificity test were performed on the basis of standard methods and then 
performed on the DNA extracted of samples. 
Results: PCR product was amplified by 272 bp and was observed on 2% gel electrophoresis. 
Specificity test with DNA of other microorganisms showed 100% specificity of these 
primers. The limit of detection was evaluated 100 copy/reaction. From 70 samples of 
synovial fluid, 2 samples (3%) were positive and 68 cases (97%) were negative. 
Conclusion: This study showed that a number of infectious arthritis are Mycoplasma spp at 
the same time, and the PCR technique can be used as a sensitive and accurate way of early 
detection of Mycoplasma spp arthritis. 
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Introduction 
Mycoplasma refers to the Greek word 
Mykes, called mushrooms and plasma. For 
the first time it was used in the 1950's to 
describe the PPLO. This term was first 
used to describe the grown form of 
Mycoplasma mycoides, but after a short 
time it was used for all PPLOs of human 
and animal origin identified at that time 
(1).                                   
Arthritis is the most common joint disease 
worldwide with many causes. Some of 
these causes are basically inflammatory, 
such as inflammatory arthritis and 
rheumatoid arthritis, although the cause of 
osteoarthritis was primarily attributed to 
destruction of the joint, associated with 
little inflammation. After many years of 
research it was found that in spite of any 
treatment to eliminate the causes of joint 
destruction, the disease continued and the 
inflammation process became even more 
important in this disease (2). Bacterial or 
septic arthritis is one of the most common 
and most important infectious arthritis and 
medical emergencies, especially in 
children. Therefore, prompt diagnosis and 
timely drug and surgical treatments may 
reduce the likelihood and severity of 
permanent injuries and prevents damage to 
the growth plate and synovium in children 
(3). Arthritis actually refers to more than 
110 types of rheumatoid arthritis, which 
affect joints, muscles, tendons and even 
skin and internal organs.                                                                                                                                            
In a study conducted in 2010, two cases of 
infectious arthritis have been associated 
with Mycoplasma hominis after knee 
replacement (4). Another study of bacterial 
arthritis has described Mycoplasma 
hominis, after Staphylococcus aureus and 
Streptococci, as a cause of infectious 
arthritis (5, 6). In another study on 
synovial fluid in 24 patients with arthritis, 
positive Mycoplasma pneumonia was 
reported in 19 cases (79%). In this study, 
all 6 patients with inflammatory and non-
inflammatory arthritis, i.e. 100%, and 8 
out of 10 patients with osteoarthritis, i.e. 
80%, were reported positive in terms of 
Mycoplasma pneumonia (7). In another 
study by Petrov on blood and joint blood 
samples of 418 patients with rheumatoid 
arthritis, Mycoplasma arthritis (20.5%, 
15.5%), Mycoplasma fermentans (15.6%, 
13.2%) and Chlamydia trachomatis 
(18.4%, 13.2%) were reported in blood 
and fluid samples, respectively.                                                                                                                                        
Diagnosis of arthritis is based on blood 
tests and radiology. Infection arthritis in 
joints is associated with many diagnostic 
challenges in most cases and identification 
and treatment require a combination of 
identification methods to identify the exact 
type of arthritis. Diagnostic methods 
currently include: 1) characteristics and 
symptoms, 2) analytical results, 3) 
microbiological tests.                                                                              
The culture-based microbiology is very 
time consuming to detect and diagnose 
mycoplasma. The discovery and invention 
of molecular techniques have created 
faster ways to trace pathogenic bacteria. 
The polymerase chain reaction technique, 
based on the natural phenomenon of DNA 
replication in cells, theoretically provides 
the possibility to trace even a single 
bacterial cell in a sample. Using this 
technique, a copy of the gene turns into 
over billions of copies within a few hours, 
making it easier to track them later. 
Various types of PCR methods have been 
used to trace genomic DNA of bacteria 
and have had good results as well (9). 
Infectious arthritis is one of the major 
emergencies of infectious medicine and 
rheumatology by which most young 
people get infected. Therefore, the correct 
management of the disease needs to up-to-
date information about arthritis and 
methods for diagnosis and treatment. 
Various studies have been conducted 
based on PCR-based molecular probe 
methods for detecting human and animal 
mycoplasmas. Fast diagnosis and no need 
to bacterial culture, considering bacteria 
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are advantages of this method (10). The 
aim of this study was rapid molecular 
diagnosis of mycoplasma arthritis by PCR. 
 
Materials and Methods 
In this study, the species belonging to the 
Mollicutes included: Mycoplasma 
pneumonia (NCTC 10119), Mycoplasma 
arginini, Mycoplasma hyorhinis, 
Mycoplasma orale, Mycoplasma synoviae, 
Mycoplasma gallinarum (Razi 1967), 
Mycoplasma gallisepticum (Razi 1976), 
Mycoplasma ovipneumoniae (Razi 1986), 
Mycoplasma agalactiae (Razi 1964), 
Ureaplasma urealyticum (Razi, 1990), and 
Ecoleplasma Laid Levi was extracted from 
standard DNA strain by DNG-PLUS. In 
this study, 70 synovial fluid specimens of 
those suffering from arthritis confirmed by 
a specialist were collected from 
rheumatology ward of Shariati hospital. 
Boiling+Phenol/chloroform carried out 
DNA extraction of the synovial fluid 
specimens. The compounds required for 
polymerase chain reaction in 25 μl were 
prepared as follows: 5 μl of template 
DNA, 1 μl of each forward and reverse 
primers, 2.5 μl of PCR buffer (10X) 
(sinaclon), 0.75 μL MgCl2 with a 
concentration of 50 mM (sinaclon), 0.5 μl 
of the mixture of dNTP (10mM) (sinaclon) 
and 0.3 μL of Taq DNA Polymerase 
(sinaclon) and 14 μL of sterilized 
deionized double-distilled water was used 
to calibrate the volumetric flask. The 
thermal program used and optimized was: 
93 ° C for 20 seconds, 60° C for 20 
seconds, and finally 72° C for 30 seconds, 
and the replication was performed in 40 
cycles. The PCR product, with the desired 
size (272 bp), besides the size of the 
marker and positive and negative controls, 
on Agarose gel 1.5%, were examined by 
SYBR safe (sinaclon) in the system "Gel 
Documentation" (Mager-science). To test 
the sensitivity of the primer pairs used in 
this test, different dilutions were prepared 
from the suspension of Mycoplasma 
arginini with a specific CFU, and their 
DNA was extracted. Finally, the PCR test 
was performed on samples of the specified 
number. DNA of some organisms such as 
human, mice, Mycobacterium tuberculosis, 
Pseudomonas aeruginosa, Salmonella 
typhi, and Staphylococcus aureus carried 
out specificity test. An optimized PCR test 
was performed on all specimens in several 
rounds along with positive and negative 
controls. 
Results 
PCR technique was optimized using 
MGSO and GPO-3 primers and DNA of 
various Mycoplasmas such as 
Mycoplasma pneumonia, Mycoplasma 
arginine, Mycoplasma hyorhinis, and 
Mycoplasma orale. This PCR, with DNA 
of all tested Mycoplasmas, produced 272 
bp products (Figure 1). 
 
 
Figure 1. Optimized PCR test using primers 
GPO-3, MGSO: Column M, Size Marker (1Kb 
DNA Ladder bioflux); Column 1, Positive 
control; Column 2, Negative control. 
The test sensitivity was evaluated by diluting 
the mycoplasma culture with a specific 
colony-forming unit. It was shown that the 
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Figure 2. Optimized PCR sensitivity test: M 
column, size marker (LOW Range DNA 
Ladder Thermoscientific); the first column is 
positive control; column 1: 10
6
CFU, column 2: 
10
5
CFU, Column 4: 10
3
CFU, Column 5: 100 
CFU, Column 6: 10 CFU, Column 7: 1 CFU, 
Column 8: negative control. The specificity 
test showed that the primers used did not 
produce any unwanted product with DNA of 
non-mycoplasma bacteria such as 
Mycobacterium tuberculosis, Pseudomonas, 
Salmonella typhimurium, Staphylococcus 
aureus, as well as human and mouse DNA 
(Figure 3). 
 
Figure 3. Optimized PCR specificity test: M 
column, size marker (LOW Range DNA 
Ladder Thermoscientific); the next column is 
positive control; column 1: human DNA; 
column 2: mouse DNA; column 3: 
Mycobacterium tuberculosis; column 4: 
Pseudomonas aeruginosa; column 5: 
Staphylococcus aureus; column 6: Salmonella 
typhimurium; column 7: Hepatitis B virus and 
C-: negative control. Mycoplasma 
contamination was sought in 70 samples of 
synovial fluid by PCR. Of these, 2 
contaminated specimens (3%) were detected 
through duplication of the correct piece.  
 
Figure 4. M: size marker (low range DNA 
Ladder- Thermo scientific); C-: negative 




Septic arthritis is one of the most common and 
important infectious and emergency arthritis, 
and rapid diagnosis and early onset of 
therapeutic and surgical treatments are 
necessary. In the absence of treatment, it will 
cause the possibility of permanent damage to 
the growth plate and synovium. It usually 
improves with early diagnosis and treatment. 
However, full recovery lasts for weeks or 
months. Delay in treatment may result in 
injury and destruction of the joint and loss of 
its movements, or permanent disability of the 
joint and blood infections, which may 
ultimately lead to joint replacement.                                                                                                                       
Infectious (septic) arthritis is inflammation in a 
joint caused by any joint infection, which is 
common in larger joints, such as the hip joint, 
or those exposed to the shot like knees or hand 
joints (11).                                                                                                       
Infectious arthritis might be caused by 
bacterial infection in the joints or a bacterial 
infection common with other factors such as 
fungal or mycobacterial infection. Every year 
in the United States about 20,000 arthritis 
patients are diagnosed. This increase in disease 
may be due to an increase in the elderly 
population. Also, Boston and Taiwan reported 
an increase in infectious arthritis from 8% to 
27%. Factors such as age, diabetes, 
alcoholism, and skin lesions may increase the 
risk of infectious arthritis (12). 
Septic arthritis is one of the most common and 
important infectious and emergency arthritis, 
and rapid diagnosis and early onset of 
therapeutic and surgical treatments are 
necessary. In the absence of treatment, it will 
cause the possibility of permanent damage to 
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improves with early diagnosis and treatment. 
However, full recovery lasts for weeks or 
months. Delay in treatment may result in 
injury and destruction of the joint and loss of 
its movements, or permanent disability of the 
joint and blood infections, which may 
ultimately lead to joint replacement.                                                                                                                        
This study is important because many articles 
have addressed the disease and in all the 
articles it is pointed out that the timely 
diagnosis of the condition is very important in 
its treatment because failure in timely 
diagnosis and treatment associates with 
irreparable consequences for the patient. If 
treatment of the disease is delayed, it will 
cause cartilage and bone destruction and 
disability and the joint may be lost forever or 
lead to the blood infection that is very 
dangerous. Even if the disease is very severe 
and treatment is not done, it leads to death in 
some cases. The mortality rate of infectious 
arthritis has been reported at around 5% to 
15% over the past 25 years (13).                                                                                                                                     
Diagnosis is performed by counting blood 
cells, blood culture and infectious synovial 
fluid culture, and imaging of the joint 
(radiography) (14).  
The exact cause of arthritis is unknown (15) 
but there are several reasons or grounds for it 
to be mentioned, including age (16), gender, 
genetic background (17), environmental 
factors, stress (18), and various infectious 
agents such as Mycobacterium tuberculosis 
(19), Coccilia bourne (20), some intestinal 
bacteria such as Escherichia coli, Proteus 
vulgaris (21), Klebsiella pneumonia, 
Salmonella typhi, Shigella dysenteriae, some 
oral anaerobic bacteria, such as 
Porphyromonas gingivalis (22), 
T. forsythensis, Prevotella intermedia, 
Mycoplasmas (23 and 24) including 
Mycoplasma pneumonia, Mycoplasma 
hominis, Ureaplasma urealyticum, 
Mycoplasma fermentas (25), Mycoplasma 
arthritis (26), Chlamydia trachomatis, 
Staphylococcus aureus (27) Streptococcus 
pyogenes, Gonococcus, Hemophilus influenza 
(28) and even fungal and viral infections.                                                                 
In another study on synovial fluid of 24 
patients with arthritis, Mycoplasma pneumonia 
was reported in 19 cases (79%) (29). In 
another study on synovial fluid of 131 patients 
with Rheumatoid Arthritis, using genus-
specific primer, 70 cases were Mycoplasma 
positive, i.e. 53.4%, which is significant 
compared with the current study, i.e. 3% of all 
samples (30). This may be given the study of 
Lei Zhang et al., because of the difference 
between results of the PCR test on adult 
samples compared to children that were more
accurate in adults and also better results of 
real-time PCR than conventional PCR (31). 
This suggests that owing to the abundance of 
Mycoplasma species, a method with a proper 
function, which can detect all species in a 
single time unit is necessary. Another study by 
Hadi (2011) mentioned 10% results (32). Also 
a study by Petrov et al. on the blood and 
synovial fluid of 218 RA patients indicated the 
presence of M. arthritidis in 20.5% of the 
patients' blood and 15.9% in their joints fluid 
samples (33).                                                                                                                                  
In studies conducted by Kuo et al. (2017) 
detection of M. synoviae infection by PCR in 
patients with arthritis was very fast and 
accurate and using common sequences like the 
16SRNA, it brought even more rapid and 
accurate performance (34). In studies by Haier 
(1999) on blood serum of 28 patients with 
arthritis, 8 cases (28%) were reported 
Mycoplasma fermentans positive, 5 cases 
(18%) were Mycoplasma pneumonia positive, 
6 cases (18%) Mycoplasma hominis positive, 
and one case (3%) was Mycoplasma penetrans 
positive (35).                                                                                         
In another study on synovial fluid of 24 
patients with arthritis, using Nested PCR, 19 
cases (79%) were Mycoplasma pneumonia 
positive (36). The positive results of this study 
were more than the results of the present 
study, associated with significant differences. 
However first, methodology of the study, 
second, the number of samples examined, and 
third, the geographic areas in these two studies 
were different.               
Various studies based on PCR-based 
molecular detection methods (37) were carried 
out to identify human (38) and animal (39) 
mycoplasmas that a fast diagnosis and no need 
to bacterial culture, given complex food and 
slow growth of bacteria, are among advantages 
of these methods (40).                                                                                           
Identification of bacterial DNA in synovial 
fluid of arthritis patients was done by Tena et 
al. (2001). The study was carried on 22 
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and special primers, the bacteria DNA was 
detected in the synovial fluid and studies 
have shown that presence of bacteria in the 
synovial fluid exacerbates the disease 
symptoms. The advantages of the PCR method 
is being fast and you do not need to fresh 
samples and the tests can be done even after 
taking an antibiotic or even you can use 
archived samples as well. This method can 
even detect microorganisms that have recently 
been identified and there is still no way to 
detect them. The high cost and contamination 
of the samples tested, which results in false 
positive results, are of disadvantages of this 
method (41).                                                                                   
According to Leng Z and He Q, sensitivity of 
the PCR test in the synovial fluid is weak, for 
the presence of reaction inhibitors such as 
DNase and protease may cause false negative 
results. Therefore, in PCR, little amount of 
mycoplasma DNA would not be measurable 
(42 and 43) and other PCR methods such as 
nested PCR or RT –PCR are used to improve 
sensitivity of PCR test in the synovial fluid. 
However, they have not been developed so far 
to detect Mycoplasma genus.                                                           
PCR is currently used successfully to detect a 
wide range of infections caused by viruses, 
parasites and bacteria such as mycoplasmas 
(44). In this study, the serological and PCR 
methods had the same results. The wrong 
answer of serological tests is due to the 
antibiotic application. In fact, the high 
antibody titre after 3 to 4 months of infection 
and cross-reactivity of antibodies leads to 
different results of serological and PCR tests 
(45 and 46). In the study of Kunita et al. 
(1989) the PCR method showed more 
sensitivity than blotting, hybridization and 
culture methods (47). 
 
Conclusion 
In PCR, there are several factors that can make 
this method more efficient to achieve better 
results. In this study, the PCR method was 
used for rapid detection of Mycoplasma 
arthritis. Two out of 70 samples tested were 
positive (3%). This study showed that a 
percentage of infectious arthritis could be 
resulted from Mycoplasma. Consequently, the 
molecular technique of PCR is a fast, 
sensitive, and accurate method compared with 
other methods of detecting Mycoplasmas in 
synovial fluid. 
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